Standard

Monitoring the frequency and amplitude parameters of ventricular fibrillation during artificial perfusion of the heart. / Gurianov, M. I.; Yablonsky, P. K.

In: Biomedical Engineering (New York) (English translation of Meditsinskaya Tekhnika), Vol. 54, No. 5, 01.2021, p. 323-326.

Research output: Contribution to journal › Article › peer-review

Harvard

Gurianov, MI & Yablonsky, PK 2021, 'Monitoring the frequency and amplitude parameters of ventricular fibrillation during artificial perfusion of the heart', Biomedical Engineering (New York) (English translation of Meditsinskaya Tekhnika), vol. 54, no. 5, pp. 323-326. https://doi.org/10.1007/s10527-021-10031-z

APA

Gurianov, M. I., & Yablonsky, P. K. (2021). Monitoring the frequency and amplitude parameters of ventricular fibrillation during artificial perfusion of the heart. Biomedical Engineering (New York) (English translation of Meditsinskaya Tekhnika), 54(5), 323-326. https://doi.org/10.1007/s10527-021-10031-z

Vancouver

Gurianov MI, Yablonsky PK. Monitoring the frequency and amplitude parameters of ventricular fibrillation during artificial perfusion of the heart. Biomedical Engineering (New York) (English translation of Meditsinskaya Tekhnika). 2021 Jan;54(5):323-326. https://doi.org/10.1007/s10527-021-10031-z

Author

Gurianov, M. I. ; Yablonsky, P. K. / Monitoring the frequency and amplitude parameters of ventricular fibrillation during artificial perfusion of the heart. In: Biomedical Engineering (New York) (English translation of Meditsinskaya Tekhnika). 2021 ; Vol. 54, No. 5. pp. 323-326.

BibTeX

@article{1df188f6e56f4ff48fab398919be50ac,
title = "Monitoring the frequency and amplitude parameters of ventricular fibrillation during artificial perfusion of the heart",
abstract = "A method for monitoring the frequency and amplitude parameters of ventricular fibrillation (VF) during artificial perfusion of the heart is described. The method is based on spectral analysis of VF cardiosignal at 30 frequencies of 0.5 Hz width in the frequency range of 0.5-15 Hz and determining the frequency, amplitude, and relative weight of the 1st-3rd highest amplitude oscillations. The method can be used for monitoring the frequency and amplitude parameters of VF during long-term artificial perfusion of the heart.",
author = "Gurianov, {M. I.} and Yablonsky, {P. K.}",
year = "2021",
month = jan,
doi = "10.1007/s10527-021-10031-z",
language = "English",
volume = "54",
pages = "323--326",
journal = "Biomedical Engineering (New York) (English translation of Meditsinskaya Tekhnika)",
issn = "0025-8075",
publisher = "Медицина",
number = "5",

}

RIS

TY - JOUR

T1 - Monitoring the frequency and amplitude parameters of ventricular fibrillation during artificial perfusion of the heart

AU - Gurianov, M. I.

AU - Yablonsky, P. K.

PY - 2021/1

Y1 - 2021/1

N2 - A method for monitoring the frequency and amplitude parameters of ventricular fibrillation (VF) during artificial perfusion of the heart is described. The method is based on spectral analysis of VF cardiosignal at 30 frequencies of 0.5 Hz width in the frequency range of 0.5-15 Hz and determining the frequency, amplitude, and relative weight of the 1st-3rd highest amplitude oscillations. The method can be used for monitoring the frequency and amplitude parameters of VF during long-term artificial perfusion of the heart.

AB - A method for monitoring the frequency and amplitude parameters of ventricular fibrillation (VF) during artificial perfusion of the heart is described. The method is based on spectral analysis of VF cardiosignal at 30 frequencies of 0.5 Hz width in the frequency range of 0.5-15 Hz and determining the frequency, amplitude, and relative weight of the 1st-3rd highest amplitude oscillations. The method can be used for monitoring the frequency and amplitude parameters of VF during long-term artificial perfusion of the heart.

UR - http://www.scopus.com/inward/record.url?scp=85099030334&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/dc4cc060-3ebb-3f27-bceb-b98d850c7429/

U2 - 10.1007/s10527-021-10031-z

DO - 10.1007/s10527-021-10031-z

M3 - Article

VL - 54

SP - 323

EP - 326

JO - Biomedical Engineering (New York) (English translation of Meditsinskaya Tekhnika)

JF - Biomedical Engineering (New York) (English translation of Meditsinskaya Tekhnika)

SN - 0025-8075

IS - 5

ER -

ID: 74047404